Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$167.33 USD
+2.59 (1.57%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $167.32 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Johnson & Johnson has a market cap of $396.75B, which represents its share price of $164.74 multiplied by its outstanding shares number of 2.41B. As a large-cap company, JNJ's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
JNJ 167.33 +2.59(1.57%)
Will JNJ be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JNJ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JNJ
3 Medical Stocks to Consider as Markets Take a Breather
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns
TEVA Q2 Earnings Beat, Revenues Miss on Lower Generics Sales
AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised '25 EPS View
Other News for JNJ
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)
ClearBridge Value Portfolios Q2 2025 Commentary
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
European pharmaceutical stocks slip after Trump pushes for lower drug prices